All Articles

China (English)

Feature

The Sinovac vaccine has to show what it can do

After months of puzzling the world over the true efficacy of the Sinovac product, applications to the World Health Organization (WHO) and the EMA will now bring clarity. The formal approval procedures are the acid test for the data on Sinovac's vaccine. It is not only the reputation of the Chinese pharmaceutical industry that is at stake. Non-approval would be a serious setback for the global supply of vaccines.

By Redaktion Table

Feature

EU Commission: Sanctions jeopardise Ratification of the CAI

It was already on the brink of collapse: The CAI investment agreement was supposed to symbolize greater proximity between China and Europe, but now it is becoming part of a major conflict between the trading blocs. By rejecting the agreement, Brussels is sending a signal to Beijing – and the German government, as a supporter of the agreement, is embarrassed. Meanwhile, the G7 is finding its way back to a common line in dealing with China.

By

Feature

Tesla seeks proximity to authorities

After years of ignorance, US manufacturer Tesla now urgently needs to improve its relations with the Chinese state – after all, it has an image disaster on its hands. The company is hiring additional employees, especially for this purpose. Warnings and protests from state media, authorities and customers have left their mark on the self-confident company in recent weeks. The change of heart is now intended to save its market share.

By Marcel Grzanna

Opinion

The two sides of Chinese GDP

Many economists care more about China’s per capita GDP, or income per person, than the aggregate measure. The key takeaway is that China remains a poor country, despite its phenomenal headline economic growth over the past four decades.

By Redaktion Table